BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35962798)

  • 1. Proteomic analysis and identification reveal the anti-inflammatory mechanism of clofazimine on lipopolysaccharide-induced acute lung injury in mice.
    Yang B; Gao Z; Li QS; Zhang XY; Song L; Wang YN; Wang XY; Ji LL; Xu HL; Xie H; Feng FK; Li XP; Li W; Wang R; Wang GS
    Inflamm Res; 2022 Nov; 71(10-11):1327-1345. PubMed ID: 35962798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effects of Mai-Luo-Ning injection against LPS-induced acute lung injury via the TLR4/NF-κB signalling pathway.
    Miao J; Shen J; Yan C; Ren J; Liu H; Qiao Y; Li Q
    Phytomedicine; 2022 Sep; 104():154290. PubMed ID: 35793597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
    Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
    Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fisetin Alleviates Lipopolysaccharide-Induced Acute Lung Injury via TLR4-Mediated NF-κB Signaling Pathway in Rats.
    Feng G; Jiang ZY; Sun B; Fu J; Li TZ
    Inflammation; 2016 Feb; 39(1):148-157. PubMed ID: 26272311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.
    Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C
    Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincamine, an active constituent of Vinca rosea ameliorates experimentally induced acute lung injury in Swiss albino mice through modulation of Nrf-2/NF-κB signaling cascade.
    Patangrao Renushe A; Kumar Banothu A; Kumar Bharani K; Mekala L; Mahesh Kumar J; Neeradi D; Durga Veera Hanuman D; Gadige A; Khurana A
    Int Immunopharmacol; 2022 Jul; 108():108773. PubMed ID: 35453074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple anti-inflammatory mechanisms of Zedoary Turmeric Oil Injection against lipopolysaccharides-induced acute lung injury in rats elucidated by network pharmacology combined with transcriptomics.
    Wu YZ; Zhang Q; Wei XH; Jiang CX; Li XK; Shang HC; Lin S
    Phytomedicine; 2022 Nov; 106():154418. PubMed ID: 36099655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygonatum Polysaccharide Regulates Macrophage Polarization and Improves LPS-Induced Acute Lung Injury through TLR4-MAPK/NF-
    Zhou W; Hong J; Liu T; Li M; Jin H; Wang X
    Can Respir J; 2022; 2022():2686992. PubMed ID: 35874106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice.
    Nguyen N; Xu S; Lam TYW; Liao W; Wong WSF; Ge R
    Mol Med; 2022 Jun; 28(1):72. PubMed ID: 35752760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochanin A protect against lipopolysaccharide-induced acute lung injury in mice by regulating TLR4/NF-κB and PPAR-γ pathway.
    Hu X; Qin H; Li Y; Li J; Fu L; Li M; Jiang C; Yun J; Liu Z; Feng Y; Yao Y; Yin B
    Microb Pathog; 2020 Jan; 138():103846. PubMed ID: 31698051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stress.
    Dhlamini Q; Wang W; Feng G; Chen A; Chong L; Li X; Li Q; Wu J; Zhou D; Wang J; Zhang H; Zhang JS
    Mol Med; 2022 Jun; 28(1):73. PubMed ID: 35764933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Punicalagin ameliorates lipopolysaccharide-induced acute respiratory distress syndrome in mice.
    Peng J; Wei D; Fu Z; Li D; Tan Y; Xu T; Zhou J; Zhang T
    Inflammation; 2015 Apr; 38(2):493-9. PubMed ID: 25005005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ.
    Shen Y; Sun Z; Guo X
    Eur J Pharmacol; 2015 Jan; 747():45-51. PubMed ID: 25281205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
    Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
    Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway.
    Liu JX; Li X; Yan FG; Pan QJ; Yang C; Wu MY; Li G; Liu HF
    Int Immunopharmacol; 2019 Jan; 66():336-346. PubMed ID: 30521962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways.
    Wang C; Li Q; Li T
    Exp Lung Res; 2020; 46(1-2):11-22. PubMed ID: 31931639
    [No Abstract]   [Full Text] [Related]  

  • 19. Total terpenoids of Inula japonica activated the Nrf2 receptor to alleviate the inflammation and oxidative stress in LPS-induced acute lung injury.
    Zhang J; Zhang M; Zhang WH; Zhu QM; Ning J; Huo XK; Xiao HT; Sun CP
    Phytomedicine; 2022 Dec; 107():154377. PubMed ID: 36116200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
    Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
    J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.